Global Intracranial Aneurysm Market Report and Forecast 2024-2032

Global Intracranial Aneurysm Market Report and Forecast 2024-2032


Global Intracranial Aneurysm Market Report and Forecast 2024-2032

The global intracranial aneurysm market size was valued at USD 1.2 billion in 2023. It is expected to grow at a CAGR of 8.80% during the forecast period of 2024-2032, driven by rising number of intracranial aneurysms globally. The market is experiencing robust growth and is expected to reach USD 2.6 billion by 2032.

Global Intracranial Aneurysm Market Analysis

The global intracranial aneurysm market is a critical segment within the healthcare and medical device industries, focusing on the diagnosis, management, and treatment of intracranial aneurysms - bulges in blood vessels in the brain that can leak or burst, leading to hemorrhagic stroke, brain damage, or death. This market analysis provides an overview of the current state, driving factors, challenges, and future prospects of the intracranial aneurysm market.

Global Intracranial Aneurysm Market Overview

The market for intracranial aneurysm treatment and management has seen significant growth due to the rising prevalence of the condition, attributed to factors such as hypertension, smoking, genetic predispositions, and aging populations. Advancements in medical imaging technologies have also improved the detection rates of asymptomatic aneurysms, contributing to market growth. The market encompasses a range of products including surgical clips, coils, flow diverters, and stent systems, as well as emerging endovascular techniques that offer less invasive alternatives to traditional surgical approaches.

Key Drivers

Several key drivers are propelling the growth of the intracranial aneurysm market:
  • Increased Prevalence: The rising number of intracranial aneurysm cases globally due to lifestyle factors and better diagnostic capabilities.
  • Technological Advancements: Innovations in endovascular treatments and surgical equipment have enhanced treatment efficacy and safety.
  • Aging Population: Older age groups are at a higher risk for aneurysms, and the growing demographic of elderly individuals worldwide boosts the potential patient base.
  • Awareness and Screening: Improved awareness about the condition and advancements in non-invasive screening techniques have led to early detection and treatment.
Market Challenges

However, the market faces several challenges:
  • High Treatment Costs: Advanced treatments, especially endovascular procedures, can be expensive, limiting accessibility for patients in lower-income regions.
  • Risks and Complications: Despite advancements, treatments can carry risks of complications, influencing decision-making by patients and healthcare providers.
  • Regulatory Hurdles: Stringent regulatory standards for the approval of new devices and treatments can delay market entry and increase development costs.


Global Intracranial Aneurysm Market Outlook

The intracranial aneurysm market is expected to continue growing, driven by ongoing research and development efforts aimed at enhancing treatment safety, efficacy, and accessibility. The future market growth will likely be supported by:
  • Innovative Treatment Modalities: Continued innovation in device design and treatment techniques, including personalized medicine approaches.
  • Expansion in Emerging Markets: Increased healthcare investment and infrastructure improvements in developing countries.
  • Collaboration and M&A Activities: Strategic collaborations and mergers & acquisitions among key players to expand product offerings and geographic presence.
The global intracranial aneurysm market is positioned for sustained growth, fueled by technological advancements, a growing patient base, and increasing global awareness. Addressing the challenges related to treatment costs and accessibility will be crucial for maximizing the market’s potential and improving patient outcomes worldwide.

Global Intracranial Aneurysm Market Trends

The global intracranial aneurysm market is witnessing several key trends that are shaping its growth trajectory and influencing treatment paradigms. These trends reflect advancements in medical technologies, shifts in patient and healthcare provider preferences, and broader demographic changes. Understanding these trends is crucial for stakeholders aiming to navigate the market effectively.
  • Minimally Invasive Treatments
There's a clear shift towards minimally invasive procedures for the treatment of intracranial aneurysms. Endovascular techniques, such as coil embolization and flow diversion, are becoming more popular due to their reduced recovery times, lower risk of complications, and comparable efficacy to open surgery. This trend is supported by continuous improvements in device design and imaging technologies, making these procedures safer and more accessible.
  • Technological Innovations
Innovation in medical devices and imaging techniques is driving the market forward. Advanced materials are being used to create more durable and biocompatible coils and stents, while novel devices like flow diverters are offering new treatment possibilities for complex aneurysms. Furthermore, enhancements in imaging technologies, such as high-resolution MRI and CT angiography, are improving the accuracy of diagnosis and treatment planning.
  • Personalized and Precision Medicine
The market is gradually moving towards personalized treatment approaches, driven by a deeper understanding of the genetic and biological factors underlying intracranial aneurysms. Precision medicine aims to tailor treatments based on individual patient characteristics, potentially improving outcomes and reducing treatment-related risks. This approach is facilitated by advancements in genetic testing and biomarker research.
  • Global Health Demographics
The aging global population is a significant trend affecting the intracranial aneurysm market. Older individuals are at a higher risk of developing intracranial aneurysms, leading to a growing target demographic for treatment devices and services. This demographic shift, combined with overall improvements in healthcare access and quality worldwide, is expanding the potential patient base.
  • Regulatory and Reimbursement Landscape
Changes in the regulatory and reimbursement landscape are influencing market dynamics. Regulatory agencies are emphasizing the safety and efficacy of intracranial aneurysm treatments, leading to more rigorous clinical trials and approval processes. At the same time, evolving reimbursement policies are impacting the accessibility and affordability of treatments, particularly in markets with significant healthcare spending scrutiny.
  • Rising Awareness and Early Detection
Increased awareness of intracranial aneurysms among the general public and healthcare providers is leading to earlier detection and treatment. Educational campaigns, improved screening guidelines, and the availability of non-invasive diagnostic methods are contributing to this trend, potentially reducing the incidence of aneurysm-related complications and deaths.

The global intracranial aneurysm market is undergoing significant transformations, influenced by technological advancements, demographic shifts, and evolving clinical practices. Stakeholders in the market must adapt to these trends to leverage growth opportunities and address the challenges posed by an increasingly dynamic and competitive landscape.

Global Intracranial Aneurysm Market Segmentation

Market Breakup by Treatment Type
  • Surgical Clipping
  • Endovascular Coiling
  • Flow Diverters
  • Others
The global intracranial aneurysm market, segmented by treatment type into surgical clipping, endovascular coiling, flow diverters, and others, is experiencing significant growth driven by technological advancements and increasing demand for minimally invasive procedures. Surgical clipping, a traditional treatment, remains foundational but is gradually being supplemented by less invasive methods such as endovascular coiling and flow diverters, which are gaining preference due to their reduced recovery times and lower risk profiles. The "others" category, including emerging technologies like polymer-based treatments, is also witnessing innovation. The market's future growth is poised to be driven by endovascular techniques, reflecting a shift towards minimally invasive treatments, with flow diverters and endovascular coiling leading the charge due to their efficacy and safety, meeting the growing patient and clinician preference for procedures that minimize hospital stays and facilitate quicker recoveries.

Market Breakup by End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
The global intracranial aneurysm market, segmented by end users into hospitals, ambulatory surgical centers (ASCs), and others, is shaped by evolving treatment approaches and healthcare infrastructure developments. Hospitals, being the primary care setting for intracranial aneurysm treatments due to their comprehensive facilities and access to specialized care, hold the largest market share. However, ambulatory surgical centers are rapidly growing in popularity, driven by the trend towards minimally invasive procedures that allow for same-day surgery and reduced hospital stays. The "others" category, which includes specialized clinics and research institutions, also plays a crucial role, especially in pioneering new treatments and technologies. Future market growth is anticipated to be significantly influenced by ASCs, as the demand for cost-effective, patient-friendly, and efficient healthcare settings rises, aligning with the global shift towards outpatient care models for even complex procedures like those involved in intracranial aneurysm treatment.

Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
The global intracranial aneurysm market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, each demonstrating unique growth dynamics and potential. North America leads the market, driven by advanced healthcare infrastructure, high patient awareness, and strong research and development initiatives. Europe follows closely, with a robust healthcare system and significant investments in healthcare technology. The Asia Pacific region is poised for the fastest growth, attributed to increasing healthcare expenditure, rising awareness of intracranial aneurysms, and improving healthcare facilities. Latin America and the Middle East and Africa are emerging markets, where growth is spurred by gradual improvements in healthcare infrastructure and accessibility to advanced treatments. The Asia Pacific region, in particular, is expected to be a key driver of market growth in the forecast period, due to its large population base, growing middle class, and increasing focus on healthcare reform.

Global Intracranial Aneurysm Market Competitive Landscape

The competitive landscape in the medical device sector is highly dynamic, with major players such as Medtronic, Stryker, Shanghai MicroPort Medical (Group) Co., Ltd., B. Braun SE, Terumo Corporation, Delta Surgical, Integra LifeSciences Corporation, Mizuho Medical Co. Ltd, evonos GmbH & Co. KG, and RAUMEDIC AG among others. These companies are known for their innovative products and global reach. The competition is intense, with each company striving to enhance its product portfolio, expand its market presence, and drive technological advancements to meet the evolving needs of the healthcare industry.

Key Questions Answered in the Report
  • How is the global intracranial aneurysm market performing now and how is it expected to perform in the future?
  • What factors are contributing to the growth of the intracranial aneurysm treatment and management market?
  • What are the key drivers and challenges in the market?
  • How is the shift towards minimally invasive procedures impacting the treatment of intracranial aneurysms?
  • How is the aging global population affecting the intracranial aneurysm market?
  • How is the global intracranial aneurysm market segmented by treatment type, and what drives its growth?
  • How is the global intracranial aneurysm market segmented by end users, and what trends are influencing its growth?
  • Who are the major players in the medical device sector, and how do they influence the competitive landscape?
Key Benefits for Stakeholders
  • The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global intracranial aneurysm market from 2017-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the global intracranial aneurysm market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global intracranial aneurysm industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Intracranial Aneurysm Market Overview
3.1 Global Intracranial Aneurysm Market Historical Value (2017-2023)
3.2 Global Intracranial Aneurysm Market Forecast Value (2024-2032)
4 Global Intracranial Aneurysm Market Landscape*
4.1 Global Intracranial Aneurysm Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Intracranial Aneurysm Market: Product Landscape
4.2.1 Analysis by Treatment Type
4.2.2 Analysis by Technology
5 Global Intracranial Aneurysm Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Intracranial Aneurysm Market Segmentation (2017-2032)
6.1 Global Intracranial Aneurysm Market (2017-2032) by Treatment Type
6.1.1 Market Overview
6.1.2 Surgical Clipping
6.1.3 Endovascular Coiling
6.1.4 Flow Diverters
6.1.5 Others
6.2 Global Intracranial Aneurysm Market (2017-2032) by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Ambulatory Surgical Centers
6.2.4 Others
6.3 Global Intracranial Aneurysm Market (2017-2032) by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Intracranial Aneurysm Market (2017-2032)
7.1 North America Intracranial Aneurysm Market (2017-2032) by Treatment Type
7.1.1 Market Overview
7.1.2 Surgical Clipping
7.1.3 Endovascular Coiling
7.1.4 Flow Diverters
7.1.5 Others
7.2 North America Intracranial Aneurysm Market (2017-2032) by Country
7.2.1 United States of America
7.2.2 Canada
8 Europe Intracranial Aneurysm Market (2017-2032)
8.1 Europe Intracranial Aneurysm Market (2017-2032) by Treatment Type
8.1.1 Market Overview
8.1.2 Surgical Clipping
8.1.3 Endovascular Coiling
8.1.4 Flow Diverters
8.1.5 Others
8.2 Europe Intracranial Aneurysm Market (2017-2032) by Country
8.2.1 United Kingdom
8.2.2 Germany
8.2.3 France
8.2.4 Italy
8.2.5 Others
9 Asia Pacific Intracranial Aneurysm Market (2017-2032)
9.1 Asia Pacific Intracranial Aneurysm Market (2017-2032) by Treatment Type
9.1.1 Market Overview
9.1.2 Surgical Clipping
9.1.3 Endovascular Coiling
9.1.4 Flow Diverters
9.1.5 Others
9.2 Asia Pacific Intracranial Aneurysm Market (2017-2032) by Country
9.2.1 China
9.2.2 Japan
9.2.3 India
9.2.4 ASEAN
9.2.5 Australia
9.2.6 Others
10 Latin America Intracranial Aneurysm Market (2017-2032)
10.1 Latin America Intracranial Aneurysm Market (2017-2032) by Treatment Type
10.1.1 Market Overview
10.1.2 Surgical Clipping
10.1.3 Endovascular Coiling
10.1.4 Flow Diverters
10.1.5 Others
10.2 Latin America Intracranial Aneurysm Market (2017-2032) by Country
10.2.1 Brazil
10.2.2 Argentina
10.2.3 Mexico
10.2.4 Others
11 Middle East and Africa Intracranial Aneurysm Market (2017-2032)
11.1 Middle East and Africa Intracranial Aneurysm Market (2017-2032) by Treatment Type
11.1.1 Market Overview
11.1.2 Surgical Clipping
11.1.3 Endovascular Coiling
11.1.4 Flow Diverters
11.1.5 Others
11.2 Middle East and Africa Intracranial Aneurysm Market (2017-2032) by Country
11.2.1 Saudi Arabia
11.2.2 United Arab Emirates
11.2.3 Nigeria
11.2.4 South Africa
11.2.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Medtronic
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Stryker
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Shanghai MicroPort Medical (Group) Co., Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 B. Braun SE
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Terumo Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Delta Surgical
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Integra LifeSciences Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Mizuho Medical Co. Ltd
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 evonos GmbH & Co. KG
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 RAUMEDIC AG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
List not exhaustive
18 Global Intracranial Aneurysm Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings